Symbiofarm Kroksp. k.

Manufacture of food supplements

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2025-02-10
Registered address
160, 38-120 Nowa Wieś, Poland

Financials

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 16.92mMedianUSD 344.81kAverageUSD 8.15m
Net profit
This companyUSD 3.17mMedianUSD 4.87kAverageUSD 684.24k
Operating costs
This companyUSD 12.75mMedianUSD 396.72kAverageUSD 7.18m
Assets
This companyUSD 10.15mMedianUSD 373.21kAverageUSD 7.89m

Bank accounts

Registered as a VAT taxpayer on 2011-10-11. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

20 public aid cases recorded, with a total value of $158,307.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
—
De minimis aid (in accordance with Commission Regulation 2023/2831)
—
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
—

European Funds

ProjectEU co-financing
Rozwój eksportu firmy SYMBIOFARM Sp. z o.o.
$89,005

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Michał Tomczyk — Attorney-in-fact (sole)

Manner of representation

Each of the general partners acting independently is authorized to represent the company. The authorization to represent covers all judicial and extrajudicial acts.

Partners

Partners
Paweł Krok (53)Marital property agreement (separation)
Michał Tomczyk

Competitors

Name
Global Pharma CmS.A.
ALG Pharmasp. z o.o.
Laboratoria Naturysp. z o.o.
Norsa Pharmasp. z o.o.
Yangosp. z o.o.
OnesanoS.A.

FAQ

Last updated: 2026-09-25